Vaxcyte (PCVX) Stock Chart - Revenue & Earnings | Quarter Chart

📊 Income Statement

Revenue by Product

Revenue by Geography

Revenue, Gross Profit, Operating and Net Income

Margin (%)

Operating Expenses

Research And Development ExpensesSelling And Marketing ExpensesGeneral And Administrative ExpensesOther Expenses
038M75M112M150M188M225M262M300MQ2 2024Q3 2024Q4 2024Q1 2025Q2 2025

EBITDA

EBITDA
-300M-262M-225M-187M-150M-112M-75M-37M1Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025

EPS

Revenue Variation (%)

Income Variation (%)

Gross Profit VariationOperating Income VariationNet Income Variation
012253850627588100Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025

Revenue YoY Variation (%)

Revenue YoY Variation
-200-175-150-125-100-74-49-241Q4 2024

Income YoY Variation (%)

Gross Profit YoY VariationOperating Income YoY VariationNet Income YoY Variation
03875112150188225262300Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025

Price-to-Earning Ratio

P/E Ratio
-40-35-30-25-20-14-9-41Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025

Income Breakdown

Per Share Metrics

Operating IncomeInterest IncomeTotal Other Income Expenses NetNet Income
025M50M75M100M125M150M175M200MQ2 2024Q3 2024Q4 2024Q1 2025Q2 2025

Expense Ratios

💰 Cash Flow Statement

Operating Cash Flow

Free Cash Flow

Operating Cash FlowCapital ExpenditureFree Cash Flow
04M8M11M15M19M22M26M30MQ2 2024Q3 2024Q4 2024Q1 2025Q2 2025

Cash Flow to Debt Ratio

Cash At End Of Period
0250M500M750M1B1B2B2B2BQ2 2024Q3 2024Q4 2024Q1 2025Q2 2025
🏦 Balance Sheet
📈 Key Metrics